Latest news
Loading news…
Nektar Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. San Francisco, California, United States Founded 1990 101-250 employees For Profit
Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.
Nektar Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Nektar Therapeutics was acquired by Ampersand Capital Partners in 2024.
Total Funding
$2.09B
Funding Rounds
10
Last Funding
Acquisitions
2
Investments
1
1 exits
Monthly Visits
Contacts
529
Ticker
NKTR
NASDAQ
Patents
343
16 trademarks
About Nektar Therapeutics
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- NKTR
- Exchange
- NASDAQ
- IPO date
- May 13, 1994
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 32
- Active products
- 23
- Patents granted
- 343
- Trademarks
- 16
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $1.19M
Investor Activity
- Investments
- 1
- Lead investments
- 1
- Portfolio orgs
- 1
- Exits
- 1
Company Info
- Founded
- 1990
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 1
- News articles
- 614
- Events
- 1
- HQ
- San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Exit date
- May 13, 1994
Signals & Scores
- Heat score
- Low
- Growth score
- High
- Trend (7d)
- -0.1
- Trend (30d)
- -2.3
- Trend (90d)
- -2.7
- Last leadership hire
- Jun 19, 2026
- Last layoff mention
- Apr 17, 2023
Nektar Therapeutics Funding Rounds
10 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 10Show
Page 1 / 2
Nektar Therapeutics Investments
Loading columns…
0 of 0Show
Page 1 / 1
Nektar Therapeutics Acquisitions
2 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| Aerogen | $32M | 2005-10-21 | Nektar Therapeutics | BiotechnologyHealth CareManufacturingMedical | Ireland |
| Shearwater Corp. | $164M | 2001-07-02 | Nektar Therapeutics | Pharmaceutical | United States |
1–2 of 2Show
Page 1 / 1
Nektar Therapeutics Key People
President and Chief Executive Officer
Senior Vice President, Human Resources and Facilities Operations
Senior Vice President and Chief Medical Officer
SVP Finance & Chief Accounting Officer
Chief Research and Development Officer
Chief Commercial Officer
Member of the Board of Directors
Member of the Board of Directors
Senior Vice President and Chief Medical Officer
Member of the Board of Directors
Senior Vice President, Technology Assessment and Quality Assurance
SVP, Strategy and Corporate Affairs
Member of the Board of Directors
Vice President, Head of Operations Europe
529
professional contacts at Nektar Therapeutics
Contact execs at Nektar Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Nektar Therapeutics
Loading news…
FAQs about Nektar Therapeutics
People who checked this page also checked these
Sectors Nektar Therapeutics invests & acquires in
Browse the full Acquirezy directory.